In addition, the blocking effect of VEGF to inhibit cell progression also promoted the development of chemotherapeutic drug sensitivity in cancer cells, allowing them to initiate antibody- and complement-mediated toxic effects that used immune mechanisms to destroy cancer cells, thereby reducing or stabilizing serum CYFRA21-1 and ProGRP levels. Here, GRP is linked to cancer.